Firas Alnidawi

Dr. Firas Alnidawi


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in The Neurologist
Verified
Journal Article
Open access
FAFiras Alnidawi
Firas Alnidawi
MMMohamed Wael Mohamed
Mohamed Wael Mohamed
NANoora Alkhater
Noora Alkhater
TATalip Asil
Talip Asil
MFMariam Fida
Mariam Fida
Introduction: Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) is a rare autosomal recessive etiology of cerebral small-vessel disease. The bulk of CARASIL cases reported in the literature was from Japan and China. Herein, we report the first genetically confirmed case of CARASIL in the Arabic population. Case Presentation: We present the case of a 35-year-old Bahraini woman diagnosed with an acute ischemic stroke after experiencing right-sided weakness and slurred speech. She had complained of persistent headaches, decreased memory, hair loss, joint pain, and personality changes. CARASIL was suspected on her medical history and brain imaging results, and genetic testing confirmed the diagnosis. Conclusion: This case contributes to our understanding of CARASIL, which is an extremely rare disease. It adds to the growing data on disease reporting outside China and Japan. We also report the first case of CARASIL in an Arabic patient and describe magnetic resonance spectroscopy finding partially different from what has been reported before.

15 October 2022 in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Verified
Journal Article
Open access
PDF file
FAFiras Alnidawi
Firas Alnidawi
MMMohamed Wael Mohamed
Mohamed Wael Mohamed
AHAli Hussein
Ali Hussein
NANoora Alataibi
Noora Alataibi
RARawan Althahabi
Rawan Althahabi
PDPriya Das
Priya Das
Background: Intracranial atherosclerotic stenosis (ICAS) is one of the most common causes of stroke worldwide. This study aimed to analyze the demographic and risk factor profiles of ICAS in the Kingdom of Bahrain. The study population included 477 patients who were hospitalized in the Neurology Department from March 1, 2018, to September 1, 2020 because of acute ischemic stroke and underwent arterial brain imaging (CTA or MRA) examination during their hospitalization. Results: Of 477 patients, 123 (25.7%) had ICAS. A history of stroke/transient ischemic attack was significantly higher in patients with intracranial stenosis (P = 0.012). Patients with ICAS had significant concurrent extracranial arterial stenosis (ECAS) (P = 0.00). In Bahraini patients, dyslipidemia was associated with a higher percentage of developing ICAS, but this was statistically nonsignificant (p = 0.06). Conclusions: An independent and significant correlation was found between ICAS and stroke recurrence. In addition, a concurrent existence of ECAS and ICAS was noted.

21 April 2026 in Australian Journal of Rural Health
Verified
Journal Article
Open access
SCStephanie Caldwell
Stephanie Caldwell
BGBronwyn Griffin
Bronwyn Griffin
RNRamon Navarro
Ramon Navarro
MCMichael Crowe
Michael Crowe
FAFiras Alnidawi
Firas Alnidawi
EFElizabeth Forster
Elizabeth Forster
Background: One comprehensive stroke centre (CSC), in North Queensland, Australia, supports almost 700 000 people across 750 000 km 2 . Access to urgent ischaemic stroke treatment is challenging for remote and regional residents, who are more likely to carry stroke risk factors and have a 17% higher stroke incidence than those in major cities. Aims: To review and report on patient demographics, stroke characteristics, interventions, and outcomes of ischaemic stroke in this regional population. Methods: Retrospective review of admissions to a North Queensland CSC (March 2022—September 2023) with acute ischaemic stroke (ICD‐10‐AM: 163). Results: Among 305 patients, the median age was 72 years, 57% were male, and 10.5% identified as First Nations. Common stroke risk factors included hypertension (83%), smoking background (58%) and hypercholesterolaemia (57%). Stroke aetiology was unknown in 42%, followed by cardioembolic (31%). Median onset‐to‐emergency department time was 90 min, and to the CSC was 343 min. Thrombolysis was administered to 6% at the referring facility, and 7% on arrival to the CSC (median door‐to‐needle time, 73 min). Endovascular clot retrieval occurred in 11.7% of the primary presenters, with an overall successful recanalisation rate of 89%. The 6‐month mortality rate was 22%. Conclusions: High rates of modifiable risk factors require improved community management. Delayed presentation highlights potential gaps in stroke awareness and access to healthcare in this region. Reaching timely reperfusion targets should become a priority, which requires support from multiple stakeholders. The high proportion of unknown aetiologies may reflect incomplete stroke work‐up, documentation, or loss to follow‐up. Targeted stroke education for regional and remote communities and healthcare providers is recommended.